We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+16.25%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.73B
AUM Growth
-$187M
Cap. Flow
-$401M
Cap. Flow %
-23.22%
Top 10 Hldgs %
38.99%
Holding
343
New
37
Increased
19
Reduced
205
Closed
33

Top Buys

Rank Stock Value
1
COHR icon
Coherent
COHR
+$20M
2
ARW icon
Arrow Electronics
ARW
+$18M
3
TMO icon
Thermo Fisher Scientific
TMO
+$15.1M
4
IP icon
International Paper
IP
+$11.7M
5
DVA icon
DaVita
DVA
+$11.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$44.6M
2
MSFT icon
Microsoft
MSFT
+$35.2M
3
AMZN icon
Amazon
AMZN
+$28.6M
4
AKAM icon
Akamai
AKAM
+$21.3M
5
CNC icon
Centene
CNC
+$21.3M

Sector Composition

Rank Sector Weight
1 Technology 37.84%
2 Consumer Discretionary 16.07%
3 Healthcare 13.89%
4 Financials 9.26%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHD icon
176
Cactus
WHD
$5.7B
$215K 0.01%
+8,260
New +$187K
RVLP
177
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$214K 0.01%
51,890
-130
-0.2% -$749
BBIO icon
178
BridgeBio Pharma
BBIO
$16.6B
$213K 0.01%
2,990
-10
-0.3% -$482
BPMC
179
DELISTED
Blueprint Medicines
BPMC
$209K 0.01%
1,860
– –
LPX icon
180
Louisiana-Pacific
LPX
$5.2B
$207K 0.01%
5,570
+2,880
+107% +$96.5K
EXLS icon
181
EXL Service
EXLS
$5.32B
$202K 0.01%
11,850
-50
-0.4% -$793
MDP
182
DELISTED
Meredith Corporation
MDP
$198K 0.01%
+10,330
New +$168K
HALO icon
183
Halozyme
HALO
$12.2B
$190K 0.01%
4,440
– –
TGTX icon
184
TG Therapeutics
TGTX
$7.52B
$183K 0.01%
3,510
-10
-0.3% -$338
HSTM icon
185
HealthStream
HSTM
$859M
$173K 0.01%
7,940
-20
-0.3% -$402
NVTA
186
DELISTED
Invitae Corporation
NVTA
$168K 0.01%
4,030
– –
MTH icon
187
Meritage Homes
MTH
$4.69B
$162K 0.01%
3,920
-20
-0.5% -$945
POLY
188
DELISTED
Plantronics, Inc.
POLY
$156K 0.01%
+5,780
New +$127K
APLS
189
DELISTED
Apellis Pharmaceuticals
APLS
$148K 0.01%
2,580
-10
-0.4% -$423
KFRC icon
190
Kforce
KFRC
$1.04B
$148K 0.01%
3,510
-10
-0.3% -$396
LMNX
191
DELISTED
Luminex Corp
LMNX
$143K 0.01%
6,200
-10
-0.2% -$232
BHVN
192
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$141K 0.01%
1,650
-10
-0.6% -$847
SANM icon
193
Sanmina
SANM
$10.7B
$138K 0.01%
4,340
– –
ALLK
194
DELISTED
Allakos
ALLK
$134K 0.01%
960
– –
INSM icon
195
Insmed
INSM
$29.4B
$134K 0.01%
4,030
– –
PTCT icon
196
PTC Therapeutics
PTCT
$6.23B
$132K 0.01%
2,170
– –
KBH icon
197
KB Home
KBH
$3.47B
$131K 0.01%
3,920
-10
-0.3% -$359
BRK.B icon
198
Berkshire Hathaway Class B
BRK.B
$1.14T
$130K 0.01%
560
-19
-3% -$4.18K
EBS icon
199
Emergent Biosolutions
EBS
$229M
$129K 0.01%
1,440
-10
-0.7% -$918
CDNA icon
200
CareDx
CDNA
$2.44B
$120K 0.01%
1,650
– –
6 7
8
9 10

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Smith Group Asset Management held 343 positions worth $1.73B, down 9.7% from $1.91B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Smith Group Asset Management withdrew a net $401M in Q4 2020, closing 33 positions and reducing 205 holdings. Its most notable exit was Akamai, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Smith Group Asset Management opened a new position in Coherent worth $25.7M.

  • Smith Group Asset Management's largest Q4 2020 buy was Coherent: 337,249 shares worth $25.7M.
  • Smith Group Asset Management added most to Thermo Fisher Scientific in Q4 2020, an estimated $15.1M increase.
  • Smith Group Asset Management's biggest Q4 2020 reduction was Apple, cutting an estimated $44.6M.
  • Smith Group Asset Management fully exited Akamai in Q4 2020, selling an estimated $21.3M.
  • Smith Group Asset Management's ten largest holdings make up 39% of its $1.73B portfolio in Q4 2020.
  • Smith Group Asset Management opened 37 new positions and closed 33 in Q4 2020.
  • Smith Group Asset Management's portfolio value fell 9.7% quarter-over-quarter to $1.73B.

Based on Smith Group Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.